The Human Prostate PrimaCell™: Normal Prostate Epithelial Cells is for rapid (7-10 days) isolation and growth of normal prostate epithelial cells from human prostate tissues. This system features an optimal condition of tissue dissociation system, Prostate OptiTDS™ that yields 5-7 times of single cells more than most of the tissue dissociation protocols published in the literature. In addition, this system ensures a high viability of the target cells with improved gradient contained in the culture medium. With CHI's proprietary fibroblast inhibitory system, FibrOut™, cells are growing with minimal amount of the unwanted cells such as fibroblasts.

Human Prostate PrimaCell™ System (Cat No. 2-96099):
Human Prostate PrimaCell™: Normal Prostate Epithelial Cells Protocols
Human Prostate Tissue Preparation Buffer: Normal Prostate Epithelial Cells
Human Prostate OptiTDS™: Tissue Dissociation System
Human Prostate FibrOut™: Fibroblast Inhibitory System (for 500 ml medium)
Human Prostate PrimaCell™: Normal Prostate Epithelial Cells Growth Medium
Human Prostate PrimaCell™: Normal Prostate Epithelial Cells Growth Supplements with Serum (for 500 ml medium)

References:

[1] Larré S, Camparo P, Comperat E, Boulbés D, Haddoum M, Baulande S, Soularue P, Costa P, Cussenot O. Biological effect of human serum collected before and after oral intake of Pygeum africanum on various benign prostate cell cultures. Asian J Androl. 2012 May;14(3):499-504. doi: 10.1038/aja.2011.132. Epub 2011 Dec 26.
[2] Rhim JS, Li H, Furusato B. Novel human prostate epithelial cell culture models for the study of carcinogenesis and of normal stem cells and cancer stem cells. Adv Exp Med Biol. 2011;720:71-80. Review.
[3] Hail N Jr, Chen P, Bushman LR. Teriflunomide (leflunomide) promotes cytostatic, antioxidant, and apoptotic effects in transformed prostate epithelial cells: evidence supporting a role for teriflunomide in prostate cancer chemoprevention. Neoplasia. 2010 Jun;12(6):464-75.